Renaissance Technologies — REGN Trade History
Quarter-by-quarter changes in the REGENERON PHARMACEUTICALS position · CUSIP 75886F107
Currently held · 5 YearsFirst seen: 2019 Q4
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-13 | Add | 148,222 | 81,420 | +121.9% | $92.4M | 0.13% |
| 2026 Q1 | 2026-05-14 | Add | 66,802 | 57,720 | +635.5% | $51.6M | 0.08% |
| 2025 Q4 | 2026-02-12 | Reduce | 9,082 | -266,080 | -96.7% | $7.0M | 0.01% |
| 2025 Q3 | 2025-11-13 | Add | 275,162 | 230,100 | +510.6% | $154.7M | 0.20% |
| 2025 Q2 | 2025-08-13 | Reduce | 45,062 | -33,839 | -42.9% | $23.7M | 0.03% |
| 2025 Q1 | 2025-05-14 | Reduce | 78,901 | -168,842 | -68.2% | $50.0M | 0.08% |
| 2024 Q4 | 2025-02-13 | Add | 247,743 | 36,320 | +17.2% | $176.5M | 0.26% |
| 2024 Q3 | 2024-11-13 | Add | 211,423 | 26,261 | +14.2% | $222.3M | 0.33% |
| 2024 Q2 | 2024-08-09 | Add | 185,162 | 19,800 | +12.0% | $194.6M | 0.33% |
| 2024 Q1 | 2024-05-13 | Reduce | 165,362 | -77,700 | -32.0% | $159.2K | 0.25% |
| 2023 Q4 | 2024-02-13 | Add | 243,062 | 81,000 | +50.0% | $213.5K | 0.33% |
| 2023 Q3 | 2023-11-14 | Add | 162,062 | 73,862 | +83.7% | $133.4K | 0.23% |
| 2023 Q2 | 2023-08-11 | Reduce | 88,200 | -26,700 | -23.2% | $63.4K | 0.09% |
| 2023 Q1 | 2023-05-12 | Reduce | 114,900 | -76,541 | -40.0% | $94.4K | 0.13% |
| 2022 Q4 | 2023-02-13 | Reduce | 191,441 | -16,959 | -8.1% | $138.1K | 0.19% |
| 2022 Q3 | 2022-11-14 | Reduce | 208,400 | -374,662 | -64.3% | $143.6M | 0.20% |
| 2022 Q2 | 2022-08-12 | Add | 583,062 | 303,200 | +108.3% | $344.7M | 0.41% |
| 2022 Q1 | 2022-05-13 | Reduce | 279,862 | -3,100 | -1.1% | $195.5M | 0.23% |
| 2021 Q4 | 2022-02-11 | Add | 282,962 | 181,700 | +179.4% | $178.7M | 0.22% |
| 2021 Q3 | 2021-11-12 | New | 101,262 | 101,262 | — | $61.3M | 0.08% |
| 2021 Q2 | 2021-08-13 | Sold out | — | -65,152 | -100.0% | — | — |
| 2021 Q1 | 2021-05-13 | Reduce | 65,152 | -839,800 | -92.8% | $30.8M | 0.04% |
| 2020 Q4 | 2021-02-10 | Reduce | 904,952 | -167,410 | -15.6% | $437.2M | 0.47% |
| 2020 Q3 | 2020-11-13 | Add | 1,072,362 | 182,262 | +20.5% | $600.3M | 0.60% |
| 2020 Q2 | 2020-08-13 | Add | 890,100 | 402,738 | +82.6% | $555.1M | 0.48% |
| 2020 Q1 | 2020-05-14 | Add | 487,362 | 198,962 | +69.0% | $238.0M | 0.23% |
| 2019 Q4 | 2020-02-13 | New | 288,400 | 288,400 | — | $108.3M | 0.08% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.